Inferior Vena Cava Filters Market By Product Type (Permanent IVC filter, Retrievable IVC filter, Others), By End User (Hospitals, Ambulatory surgical centres, Others) and Geography 


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

The global Inferior Vena Cava (IVC) Filters Market is expected to grow at a CAGR of 9.4% during the forecast period 2022 to 2028. Inferior Vena Cava Filters Market is a device implanted in inferior vena cava, the largest vein in the human body. The inferior vena cava filter is inserted below the kidneys to prevent the risk of pulmonary embolism (PE) and deep vein thrombosis (DVT) when anticoagulation therapy is contraindicated in the patients. The inferior vena cava filters are work by permitting the blood flow around the trapped clot.  The commercially available inferior vena cava filters include temporary filters and pulmonary filters. Global IVC filters market is growing at a healthy CAGR owing to increase in the prevalence of deep vein thrombosis. According to the International Society of Thrombosis and Haemostasis, Inc. (ISTH), approximately 10 Mn cases of venous thromboembolism occur annually around the globe. The most commonly adopted strategies by industry players include new product launches with technological advances, new product approvals, acquisitions & mergers, agreements, and collaborations to capture significant venous thromboembolism market share. For instance, in December 2012, Volcano Corporation acquired Crux Biomedical for developing its inferior vena cava product portfolio. Similarly, in April 2013, Argon Medical Devices, Inc. has acquired Angiotech Interventional Business for the development of inferior vena cava product portfolio. Moreover, favourable initiatives by the regulatory bodies also expected to boost the IVC market. For instance, in May 2014, FDA released the post-market surveillance of IVF filters which provides the implementation of filters and risk of pulmonary embolism.

Global Inferior Vena Cava Filters Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Inferior Vena Cava Filters Market Dynamics

Inferior vena cava filters market is driven by the increase in the prevalence of various cardiac ailments, rise in the R&D activities increase in the government support, an increase in the technological advancements with improved medical imaging are anticipated to drive the growth of inferior vena cava filters market over the forecast period. In addition, the launching of new products, an involvement of market players for increased awareness among the key stakeholders, and minimally invasive procedure for the implantation might fuel the growth of inferior vena cava filters market. However, stringent regulatory guidelines, a high cost of the device, and lack of awareness regarding IVC filters in developing countries might hamper the growth of inferior vena cava filters market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Inferior Vena Cava Filters Market Segmentation

Product Type
  • Permanent IVC filter
  • Retrievable IVC filter
  • Others
End User
  • Hospitals
  • Ambulatory surgical centres
  • Others
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Accellent, Inc. (U.S)
  • Biosensors International Group, Ltd. (Singapore)
  • Fukuda Denshi Co., Ltd. (Japan)
  • Baxter International, Inc. (U.S)
  • Boston Scientific Corporation (U.S)
  • Cardinal Health, Inc. (U.S)
  • Argon Medical Devices (U.S)
  • Abbott Laboratories (U.S)
  • B. Braun Melsungen AG (Germany)
  • Medtronic plc (Ireland)
  • Volcano Corporation (U.S)